EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bacteriophage treatment is effective against carbapenem-resistant Klebsiella pneumoniae (KPC) in a neutropenic murine model of gastrointestinal translocation and renal infection

Panagiotis Zagaliotis iD, Jordyn Michalik-Provasek, Eleftheria Mavridou, Ethan Naing, Ioannis S Vizirianakis, Dimitrios Chatzidimitriou, Jason J Gill iD, Thomas J Walsh iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.00919-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Panagiotis Zagaliotis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Transplantation/Oncology Program, Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Klebsiella Infections, Bacteriophages, Neutropenia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbapenemase-producing Klebsiella pneumoniae (KPC) are globally emerging pathogens that cause life-threatening infections. Novel treatment alternatives are urgently needed. We therefore investigated the effectiveness of three novel bacteriophages (Spivey, Pharr, and Soft) in a neutropenic murine model of KPC gastrointestinal colonization, translocation, and disseminated infection. Bacteriophage efficacy was determined by residual bacterial burden of KPC (CFU/g) in kidneys. Parallel studies were conducted of bacteriophage pharmacokinetics and resistance. Treatment of mice with 5 × 10 9 PFU of phage cocktail via intraperitoneal injection was effective in significantly reducing renal KPC CFU by 100-fold ( P < 0.01) when administered every 24 h and 1000-fold ( P < 0.01) every 12 h. Moreover, a combination of bacteriophage and ceftazidime-avibactam produced a synergistic effect, resulting in a 10 5 -fold reduction in bacterial burden in cecum and kidney ( P < 0.001 in both tissues). Prophylactic administration of bacteriophages via oral gavage did not prevent KPC translocation to the kidneys. Bacteriophage decay determined by linear regression of the ln of mean concentrations demonstrated R 2 values in plasma of 0.941, kidney 0.976, and cecum 0.918, with half-lives of t 1/2 = 2.5 h. Furthermore, a phage-resistant mutant displayed increased sensitivity to serum killing in vitro , but did not show significant defects in renal infection in vivo . A combination of bacteriophages demonstrated significant efficacy alone and synergy with ceftazidime/avibactam in the treatment of experimental disseminated KPC infection in neutropenic mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeKlebsiella InfectionsBacteriophagesNeutropeniaPhage TherapyCarbapenem-Resistant EnterobacteriaceaeAnimalsMiceCeftazidimeAnti-Bacterial AgentsKidneyDisease Models, AnimalAzabicyclo CompoundsDrug CombinationsFemaleCarbapenemsBacterial TranslocationMicrobial Sensitivity Testsbeta-Lactamases

Stichwörter der Autor:innen

Klebsiella pneumoniae (KPC)bacteriophagescarbapenem-resistant (KPC)gastrointestinal translocationneutropenic murine modelrenal infection

Substanzen

CeftazidimeAnti-Bacterial AgentsAzabicyclo Compoundsavibactam, ceftazidime drug combinationDrug CombinationsCarbapenemsbeta-Lactamases

Autor:innen und Institutionen

  • Transplantation/Oncology Program, Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, USA.
  • Department of Pharmacology, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Department of Microbial Pathogenesis and Immunology, Texas A&M University, College Station, Texas, USA.
  • Department of Health Sciences, School of Life and Health Sciences, University of Nicosia, Nicosia, Cyprus.
  • Deparment of Microbiology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Department of Animal Science, Texas A&M University Department of Animal Science, College Station, Texas, USA.

ORCID-Profile: Panagiotis Zagaliotis, Jason J Gill, Thomas J Walsh

Förderung

  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)

Zitieren

APA

Zagaliotis, P., Michalik-Provasek, J., Mavridou, E., Naing, E., Vizirianakis, I. S., Chatzidimitriou, D., Gill, J. J., & Walsh, T. J. (2025). Bacteriophage treatment is effective against carbapenem-resistant Klebsiella pneumoniae (KPC) in a neutropenic murine model of gastrointestinal translocation and renal infection. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00919-24

Vancouver

Zagaliotis P, Michalik-Provasek J, Mavridou E, Naing E, Vizirianakis IS, Chatzidimitriou D, et al. Bacteriophage treatment is effective against carbapenem-resistant Klebsiella pneumoniae (KPC) in a neutropenic murine model of gastrointestinal translocation and renal infection. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00919-24

BibTeX
@article{Zagaliotis2025,
  author = {Zagaliotis, Panagiotis and Michalik-Provasek, Jordyn and Mavridou, Eleftheria and Naing, Ethan and Vizirianakis, Ioannis S and Chatzidimitriou, Dimitrios and Gill, Jason J and Walsh, Thomas J},
  title = {Bacteriophage treatment is effective against carbapenem-resistant Klebsiella pneumoniae (KPC) in a neutropenic murine model of gastrointestinal translocation and renal infection},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.00919-24}
}
Kostenlos starten →